22nw Fund, Lp - Net Worth and Insider Trading

22nw Fund, Lp Net Worth

The estimated net worth of 22nw Fund, Lp is at least $54 Million dollars as of 2024-05-12. 22nw Fund, Lp is the of Anebulo Pharmaceuticals Inc and owns about 8,017,241 shares of Anebulo Pharmaceuticals Inc (ANEB) stock worth over $24 Million. 22nw Fund, Lp is the of Merrimack Pharmaceuticals Inc and owns about 1,241,896 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $19 Million. 22nw Fund, Lp is also the 10% Owner of Dirtt Environmental Solutions Ltd and owns about 16,109,034 shares of Dirtt Environmental Solutions Ltd (DRTTF) stock worth over $9 Million. Besides these, 22nw Fund, Lp also holds Strata Skin Sciences Inc (SSKN) , Armstrong Flooring Inc (AFIIQ) . Details can be seen in 22nw Fund, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that 22nw Fund, Lp has not made any transactions after 2023-08-16 and currently still holds the listed stock(s).

Transaction Summary of 22nw Fund, Lp

To

22nw Fund, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, 22nw Fund, Lp owns 7 companies in total, including Merrimack Pharmaceuticals Inc (MACK) , Dirtt Environmental Solutions Ltd (DRTTF) , and Armstrong Flooring Inc (AFIIQ) among others .

Click here to see the complete history of 22nw Fund, Lp’s form 4 insider trades.

Insider Ownership Summary of 22nw Fund, Lp

Ticker Comapny Transaction Date Type of Owner
MACK Merrimack Pharmaceuticals Inc 2019-04-17 10 percent owner & other: See Explanation of Responses
DRTTF Dirtt Environmental Solutions Ltd 2021-11-03 10 percent owner
AFIIQ Armstrong Flooring Inc 2022-05-02 10 percent owner
2022-04-21 10 percent owner
2022-09-09 10 percent owner
2023-05-17 10 percent owner
2023-08-16 10 percent owner

22nw Fund, Lp Latest Holdings Summary

22nw Fund, Lp currently owns a total of 5 stocks. Among these stocks, 22nw Fund, Lp owns 8,017,241 shares of Anebulo Pharmaceuticals Inc (ANEB) as of December 17, 2021, with a value of $24 Million and a weighting of 44.86%. 22nw Fund, Lp owns 1,241,896 shares of Merrimack Pharmaceuticals Inc (MACK) as of April 17, 2019, with a value of $19 Million and a weighting of 34.91%. 22nw Fund, Lp also owns 16,109,034 shares of Dirtt Environmental Solutions Ltd (DRTTF) as of November 3, 2021, with a value of $9 Million and a weighting of 16.48%. The other 2 stocks Strata Skin Sciences Inc (SSKN) , Armstrong Flooring Inc (AFIIQ) have a combined weighting of 3.74% among all his current holdings.

Latest Holdings of 22nw Fund, Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANEB Anebulo Pharmaceuticals Inc 2021-12-17 8,017,241 3.01 24,131,895
MACK Merrimack Pharmaceuticals Inc 2019-04-17 1,241,896 15.12 18,777,468
DRTTF Dirtt Environmental Solutions Ltd 2021-11-03 16,109,034 0.55 8,864,801
SSKN Strata Skin Sciences Inc 2023-08-16 5,369,954 0.38 2,013,733
AFIIQ Armstrong Flooring Inc 2022-05-02 8,402 0.00 2

Holding Weightings of 22nw Fund, Lp


22nw Fund, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, 22nw Fund, Lp has made a total of 4 transactions in Anebulo Pharmaceuticals Inc (ANEB) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Anebulo Pharmaceuticals Inc is the acquisition of 400 shares on December 17, 2021, which cost 22nw Fund, Lp around $2,636.

According to the SEC Form 4 filings, 22nw Fund, Lp has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 66,760 shares on April 17, 2019, which cost 22nw Fund, Lp around $391,214.

According to the SEC Form 4 filings, 22nw Fund, Lp has made a total of 6 transactions in Dirtt Environmental Solutions Ltd (DRTTF) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Dirtt Environmental Solutions Ltd is the acquisition of 244,760 shares on November 3, 2021, which cost 22nw Fund, Lp around $761,204.

More details on 22nw Fund, Lp's insider transactions can be found in the Insider Trading History of 22nw Fund, Lp table.

Insider Trading History of 22nw Fund, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

22nw Fund, Lp Trading Performance

GuruFocus tracks the stock performance after each of 22nw Fund, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by 22nw Fund, Lp is -18.87%. GuruFocus also compares 22nw Fund, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by 22nw Fund, Lp within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how 22nw Fund, Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of 22nw Fund, Lp

Average Return

Average return per transaction

Outperforming Transactions

0 out of 13 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.47
Relative Return to S&P 500(%) -3.82

22nw Fund, Lp Ownership Network

Ownership Network List of 22nw Fund, Lp

No Data

Ownership Network Relation of 22nw Fund, Lp


22nw Fund, Lp Owned Company Details

What does Merrimack Pharmaceuticals Inc do?

Who are the key executives at Merrimack Pharmaceuticals Inc?

22nw Fund, Lp is the 10 percent owner & other: See Explanation of Responses of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .

Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary

Over the past 18 months, 22nw Fund, Lp made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 100,000 shares made by Noah G. Levy , and a net purchase of 4,156 shares made by Ana Radeljevic .

In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.

Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merrimack Pharmaceuticals Inc Insider Transactions

No Available Data

22nw Fund, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for 22nw Fund, Lp. You might contact 22nw Fund, Lp via mailing address: 1455 Nw Leary Way, Suite 400, Seattle Wa 98107.

Discussions on 22nw Fund, Lp

No discussions yet.